SCHEMBL19403879

SCHEMBL19403879

CC(C)C(=O)N1CCC(c2cc(-c3ccc(NC(=O)c4nn(C(C)C)c(=O)n(-c5ccccc5)c4=O)cc3)c3c(N)ncnn23)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TYRO3 Q06418 14/20 1.00
▸ MERTK Q12866 9/20 0.71
▸ AXL P30530 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377715 0.95 TYRO3 (0.90) TYRO3MERTKAXL
SCHEMBL19377722 0.91 TYRO3 (0.83) TYRO3MERTKAXL
SCHEMBL19377772 0.90 TYRO3 (0.82) TYRO3MERTKAXL
SCHEMBL19398128 0.87 TYRO3 (1.00) TYRO3MERTKAXL
SCHEMBL19377556 0.85 MERTK (0.87) TYRO3MERTKAXL
SCHEMBL19429633 0.84 TYRO3 (1.00) TYRO3MERTKAXL
SCHEMBL19377713 0.83 MERTK (1.00) TYRO3MERTKAXL
SCHEMBL19377602 0.83 MERTK (1.00) TYRO3MERTKAXL
SCHEMBL19377506 0.82 TYRO3 (1.00) TYRO3MERTKAXL
SCHEMBL19377614 0.82 TYRO3 (1.00) TYRO3MERTKAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147430-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORPORATION 2021-05-20 — — US disclosed
US-10844069-B2 Pyrrolotriazine compounds as TAM inhibitors INCYTE CORPORATION (US) 2020-11-24 — — US disclosed
US-20200131185-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORPORATION 2020-04-30 — — US disclosed
US-10442810-B2 Pyrrolotriazine compounds as TAM inhibitors INCYTE CORPORATION (US) 2019-10-15 — — US disclosed
US-9981975-B2 Pyrrolotriazine compounds as tam inhibitors INCYTE CORPORATION (US) 2018-05-29 — — US disclosed
US-20170275290-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORPORATION 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147430-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS MERTK, MAP3K15, MAP3K5 TYRO3 106/4885MERTK 1/4885AXL 49/4885
US-10844069-B2 Pyrrolotriazine compounds as TAM inhibitors MERTK, MAP3K15, MAP3K5 TYRO3 106/4885MERTK 1/4885AXL 49/4885
US-20170275290-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS MERTK, MAP3K15, MAP3K5 TYRO3 106/4885MERTK 1/4885AXL 49/4885
US-20200131185-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS MERTK, MAP3K15, MAP3K5 TYRO3 106/4885MERTK 1/4885AXL 49/4885
US-10442810-B2 Pyrrolotriazine compounds as TAM inhibitors MERTK, MAP3K15, MAP3K5 TYRO3 106/4885MERTK 1/4885AXL 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback